Tenderwize
Zurück zur Suche

Pharmaceutical Products DPS

КОМПЛЕКСЕН ОНКОЛОГИЧЕН ЦЕНТЪР - СТАРА ЗАГОРА ЕООД·гр. Стара Загора, Bulgaria·BGN 300M·Deadline Aug 31, 2027 · 370 days left·Restricted·Supplies·DPS
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Bulgaria – Pharmaceutical products – ДСП „Доставка на лекарствени продукти“

63/100

Opportunity Score

Needs reviewHigh complexity
SuppliesDPSOpen
Warum diese Bewertung?

Chance

63 / 100

Komplexität

72 / 100

Risikofaktoren

The DPS specification may be changed during its term, including new products and quantity changes.

Participation depends on holding specific wholesale, narcotics, and radioactive-substances authorisations where applica...

Restricted procedure — pre-qualification required

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • BGN 300M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Supply of pharmaceutical products for the contracting authority's needs.
  • Medicines for treatment of solid malignant diseases.
Vollständige Zusammenfassung anzeigen

This is a Bulgarian DPS for pharmaceutical products for the needs of the Complex Oncology Center - Stara Zagora. The notice is for supplies, restricted procedure, electronic submission required, with an estimated overall value of BGN 300,000,000. The DPS scope covers medicines for solid malignant diseases, medicines from the Positive Drug List for other diseases, non-PLS medicines, and radiopharmaceuticals. Procurement documents are linked, but only the TED XML notice text was provided; the underlying procurement documents were not analyzed.

Risiken

The DPS specification may be changed during its term, including new products and quantity changes.

Participation depends on holding specific wholesale, narcotics, and radioactive-substances authorisations where applica...

Restricted procedure — pre-qualification required

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Procedure type is restricted.
  • The DPS is open for pharmaceutical supply offers matching the product specification.

Administrative

  • Electronic submission is required.

Zuschlagskriterien

Lot 1

Price: lowest unit price; weight not stated.

Auftraggeber

Ort

гр. Стара Загора, BGR

Auftraggeberprofil

Profil öffnen

Kennung

000812197

Tätigkeit

Health

Lose (1)

LOT-0001

Pharmaceutical Products DPS

Dynamic purchasing system for supply of pharmaceutical products for the contracting authority, including medicines for solid malignant diseases, medicines from the Positive Drug List for other diseases, medicines outside the Positive Drug List, and radiopharmaceuticals. Quantities in the initial specification are indicative and may be changed during the DPS, including adding new products or changing quantities. This lot information comes from the structured data and XML notice.

SuppliesDPSEU fundedElectronic submission

BGN 300M

Geschätzter Wert

Ort

BG344, Bulgaria

Dauer

Aug 2024

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Frist

Deadline Aug 31, 2027

Vergabedetails

Veröffentlichungsdatum
29 Aug 2024
Sprachen
Bulgarian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
521273-2024

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3